ELEV - Elevation Oncology, Inc.

QQQ $ 440.48 $ 2.68 (0.61 %)

DIA $ 389.72 $ 2.91 (0.75 %)

SPY $ 522.63 $ 5.25 (1.01 %)

TLT $ 96.88 $ -1.92 (-1.94 %)

GLD $ 220.73 $ -1.75 (-0.79 %)

Previous Close

$ 2.13

Open

$ 1.14

Bid

$ 0.76 x 200

Ask

-- x --

Day's Range

$ 0.76 - $ 1.14

52 Week Range

$ 0.36 - $ 5.83

Volume

1,187,954

Average Volume

Market Cap

116.25M

Beta (5Y Monthly)

$ 233.12

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-06-2024	06-30-2024	10-Q
2	05-02-2024	03-31-2024	10-Q
3	03-06-2024	12-31-2023	10-K
4	11-02-2023	09-30-2023	10-Q
5	08-03-2023	06-30-2023	10-Q
6	05-15-2023	03-31-2023	10-Q
7	03-09-2023	12-31-2022	10-K
8	11-03-2022	09-30-2022	10-Q
9	08-04-2022	06-30-2022	10-Q
10	05-05-2022	03-31-2022	10-Q
11	03-03-2022	12-31-2021	10-K
12	11-12-2021	09-30-2021	10-Q
13	08-12-2021	06-30-2021	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

sp-500-surges-over-2-caterpillar-earnings-beat-estimates

S&P 500 Surges Over 2%; Caterpillar Earnin...
08/06/2024 18:39:01

why-is-penny-stock-elevation-oncology-trading-lower-on-tuesday

Why Is Penny Stock Elevation Oncology Trad...
08/06/2024 16:36:44

Elevation Oncology shares dropped after initial data from the Phase 1 trial of EO-3021 showed a 42.8% objective response rate i...

Crude Oil Moves Higher; Yum! Brands Posts ...
08/06/2024 16:05:26

dow-jumps-over-300-points-us-trade-gap-narrows-in-june

Dow Jumps Over 300 Points; US Trade Gap Na...
08/06/2024 14:22:05

Elevation Oncology Expects Its Existing Ca...
08/06/2024 11:25:19

Elevation Oncology Q2 2024 GAAP EPS $(0.18...
08/06/2024 11:24:30

Elevation Oncology Reports Initial Data Fr...
08/06/2024 11:18:05

"We are encouraged to see the benefits of EO-3021's site-specific conjugation translate clinically, with minimal MMAE-a...

genedx-leads-russell-2000-this-year-as-it-shifts-to-more-comprehensive-genetic-testing-corrected

GeneDx Leads Russell 2000 This Year As It ...
08/02/2024 18:06:16

GeneDx Holdings Corp. (NASDAQ: WGS) has soared 1,101% this year, attributed to its mix shift towards exome/genome testing and r...

GeneDx Leads Russell 2000 This Year As It ...
08/02/2024 18:06:16

GeneDx Holdings Corp. (NASDAQ: WGS) has soared 1,101% this year, attributed to its mix shift towards exome/genome testing and r...

JMP Securities Reiterates Market Outperfor...
07/15/2024 13:46:46

JMP Securities analyst Silvan Tuerkcan reiterates Elevation Oncology (NASDAQ:ELEV) with a Market Outperform and maintains $7...

JMP Securities Reiterates Market Outperfor...
06/28/2024 14:39:23

JMP Securities analyst Silvan Tuerkcan reiterates Elevation Oncology (NASDAQ:ELEV) with a Market Outperform and maintains $7...

Elevation Oncology Plans To Expand Its Ong...
06/27/2024 11:32:22

Following recently signed clinical supply agreements with Eli Lilly and Company (Lilly) and GSK, respectively, Elevation Oncolo...

Piper Sandler Initiates Coverage On Elevat...
05/31/2024 09:56:27

Piper Sandler analyst Biren Amin initiates coverage on Elevation Oncology (NASDAQ:ELEV) with a Overweight rating and announc...

Stephens & Co. Initiates Coverage On Eleva...
05/14/2024 10:13:41

Stephens & Co. analyst Sudan Loganathan initiates coverage on Elevation Oncology (NASDAQ:ELEV) with a Overweight rating ...

12-health-care-stocks-moving-in-mondays-after-market-session

12 Health Care Stocks Moving In Monday's A...
05/13/2024 20:31:07

Wedbush Reiterates Outperform on Elevation...
05/03/2024 13:38:58

Wedbush analyst Robert Driscoll reiterates Elevation Oncology (NASDAQ:ELEV) with a Outperform and maintains $8 price target.

12-health-care-stocks-moving-in-thursdays-intraday-session

12 Health Care Stocks Moving In Thursday's...
05/02/2024 16:31:17

Elevation Oncology shares are trading lowe...
05/02/2024 16:00:16

Elevation Oncology Says Cash, Cash Equival...
05/02/2024 12:26:15

Elevation Oncology Q1 2024 GAAP EPS $(0.23...
05/02/2024 12:24:30

Elevation Oncology (NASDAQ:ELEV) reported quarterly losses of $(0.23) per share which missed the analyst consensus estimate of ...